Episode 1.7 Update on Makena and COVID, emergency contraception, and the relationship between breastfeeding and IQ

In this episode, we discuss some new literature about the effectiveness of progesterone for preterm labor as well as some new evidence implicating 17-hydroxyprogesterone as a possible endocrine disruptor that might cause increased risk of cancer. We also discuss emergency contraception and new studies in that field. Finally, we discuss the relationship between breastfeeding and IQ.

Links discussed:

Drug Used to Prevent Miscarriages May Be Upping Cancer Rates Decades Later

EPPPIC: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00217-8/fulltext

ACOG practice advisory: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/03/clinical-guidance-for-the-integration-of-the-findings-of-the-epppic-meta-analysis-evaluating-progestogens-for-preventing-preterm-birth-international-collaborative

COVID vax Harvard preg study: KJ Gray et al. COVID-19 vaccine response in pregnant and lactating women: a cohort study.

Ingested antibodies

Absorption of Maternal Antibodies

Emergency Contraception

Emergency contraception review: evidence-based recommendations for clinicians

Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception

Interventions for emergency contraception

History and Efficacy of Emergency Contraception: Beyond Coca-Cola